Xiao-Lin Pang
Overview
Explore the profile of Xiao-Lin Pang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
76
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, Zhao W, Bai S, Feng L, Bie S, Gong L, et al.
Nat Commun
. 2022 May;
13(1):2638.
PMID: 35551189
The rapid recognition of DNA double-strand breaks (DSBs) by the MRE11/RAD50/NBS1 (MRN) complex is critical for the initiation of DNA damage response and DSB end resection. Here, we show that...
2.
Liu S, He F, Guan Y, Ju H, Ma Y, Li Z, et al.
Cancer Manag Res
. 2021 Mar;
13:1777-1789.
PMID: 33654427
Purpose: Preoperative neoadjuvant therapy is standard before surgery for locally advanced rectal cancer in current clinical treatment. However, patients with the same clinical TNM stage before treatment vary in clinical...
3.
Chen H, Feng L, Li M, Ju H, Ding Y, Lan M, et al.
Oncologist
. 2021 Feb;
26(5):e780-e793.
PMID: 33543577
Background: The National Comprehensive Cancer Network's Rectal Cancer Guideline Panel recommends American Joint Committee of Cancer and College of American Pathologists (AJCC/CAP) tumor regression grading (TRG) system to evaluate pathologic...
4.
Xiao W, Li M, Guo Z, Zhang R, Xi S, Zhang X, et al.
Int J Radiat Oncol Biol Phys
. 2021 Jan;
110(2):482-491.
PMID: 33434612
Purpose: To construct and validate a predicting genotype signature for pathologic complete response (pCR) in locally advanced rectal cancer (PGS-LARC) after neoadjuvant chemoradiation. Methods And Materials: Whole exome sequencing was...
5.
He F, Yu L, Ding Y, Li Z, Wang J, Zheng J, et al.
Cancer Sci
. 2020 Aug;
111(11):4205-4217.
PMID: 32860448
Neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision and adjuvant chemotherapy is the standard regimen for patients with locally advanced rectal cancer (LARC). However, whether and to which extent neoadjuvant...
6.
Du X, Li X, Cai L, Sun J, Wang S, Wang X, et al.
J Cancer
. 2019 Jul;
10(14):3214-3223.
PMID: 31289592
: Nimotuzumab is a humanized anti-epidermal growth factor receptor (EGFR) antibody that has shown preclinical and clinical anticancer activity in cerebral glioblastoma multiforme (GBM). We conducted a phase II, single-arm,...